MedTrace Logo

Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value

NCT06097351 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2023-10-26

No results posted yet for this study

Summary

Expression analysis of urinary exosome miR-142-3p in type 2 diabetic nephropathy and evaluation of its clinical diagnostic value

Conditions

  • Diabetic Nephropathy

Interventions

OTHER

Grouping based on previous laboratory results, no intervention.

The patients were grouped according to the results of previous inpatient tests, and no intervention measures were taken

Sponsors & Collaborators

  • Yipeng Liu

    lead OTHER

Principal Investigators

  • Yipeng Liu · Qianfoshan Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2023-12-30
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06097351 on ClinicalTrials.gov